in5points
BusinessMoneycontrol

Piramal Pharma seeing broad-based revival in CDMO, complex generics, says Nandini Piramal

in5points

  1. Piramal Pharma chairperson Nandini Piramal said the company has started FY27 on a strong note, with a broad-based revival in CDMO and complex generics.

  2. The turnaround is attributed to a combination of recovering demand and operational discipline.

  3. Nandini Piramal made the statement to Moneycontrol.

5h ago · original ↗
Piramal Pharma seeing broad-based revival in CDMO, complex generics, says Nandini Piramal · in5points